3-D Matrix, Ltd. (TYO:7777)

Market Cap	25.15B
Revenue (ttm)	6.93B
Net Income (ttm)	-2.50B
Shares Out	112.28M
EPS (ttm)	-25.20
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	964,700
Average Volume	2,799,010
Open	223.00
Previous Close	224.00
Day's Range	219.00 - 224.00
52-Week Range	99.00 - 283.00
Beta	0.05
RSI	48.19
Earnings Date	Sep 11, 2025

About 3-D Matrix

3-D Matrix, Ltd. develops self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 114
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7777

Financial Performance

In 2025, 3-D Matrix's revenue was 6.93 billion, an increase of 51.13% compared to the previous year's 4.59 billion. Losses were -2.50 billion, 880.8% more than in 2024.